{
  "DOI": "10.1186/s40246-021-00314-7",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00314-7",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eMyocardial infarction (MI), a common type of coronary heart disease, is the major cause of morbidity and mortality around the world. Chemokine-mediated inflammatory cell infiltration and local inflammatory damage response are recent research hotspots. Hence, we attempted to examine the role of \u003cjats:italic\u003eC-X-C motif chemokine 16\u003c/jats:italic\u003e (\u003cjats:italic\u003eCXCL16\u003c/jats:italic\u003e) as a potential candidate in MI.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eHuman cardiomyocytes were treated with hypoxia/reoxygenation (H/R) to establish an in vitro cell model. GEO database provided the clinical data of MI patients and GSEA verified the relationship of chemokine and MI. CCK-8 and flow cytometry analyses were used to measure cell viability and apoptosis. Bioinformatics analysis and luciferase reporter assay were conducted to determine the correlation between \u003cjats:italic\u003eCXCL16\u003c/jats:italic\u003e and \u003cjats:italic\u003emiR-545\u003c/jats:italic\u003e. qRT-PCR and western blot assays were performed to investigate the expression level of the indicated genes. The activity of lactate dehydrogenase (LDH) and the levels of TNF-α, IL-6, IL-1β, and IL-10 were explored using ELISA assay.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eCXCL16 was increased in MI. CXCL16 knockdown can reverse the inhibitory effect of H/R treatment on cell viability, while overexpression of CXCL16 showed the opposite trend. \u003cjats:italic\u003eMiR-545\u003c/jats:italic\u003e directly targeted \u003cjats:italic\u003eCXCL16\u003c/jats:italic\u003e and negatively regulated CXCL16 levels. \u003cjats:italic\u003eMiR-545\u003c/jats:italic\u003e promoted cell proliferation and inhibited apoptosis in the MI cell model, which attenuated the CXCL16-induced injury on cardiomyocytes.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eThese findings demonstrated that \u003cjats:italic\u003eCXCL16\u003c/jats:italic\u003e aggravated MI damage through being directly targeted by \u003cjats:italic\u003emiR-545\u003c/jats:italic\u003e and mediating inflammatory responses, thereby providing potential therapeutic targets for MI therapy.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "314"
  ],
  "article-number": "15",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "18 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "11 February 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "26 February 2021"
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Liang",
      "given": "Fang-Qian",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Jing-Yuan",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-4402-7331",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Liu",
      "given": "Ji-Wei",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        2,
        26
      ]
    ],
    "date-time": "2021-02-26T10:08:40Z",
    "timestamp": 1614334120000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        2,
        26
      ]
    ],
    "date-time": "2021-02-26T10:17:26Z",
    "timestamp": 1614334646000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        1,
        21
      ]
    ],
    "date-time": "2023-01-21T06:29:31Z",
    "timestamp": 1674282571955
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        2,
        26
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            2,
            26
          ]
        ],
        "date-time": "2021-02-26T00:00:00Z",
        "timestamp": 1614297600000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by/4.0/",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            2,
            26
          ]
        ],
        "date-time": "2021-02-26T00:00:00Z",
        "timestamp": 1614297600000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-021-00314-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1186/s40246-021-00314-7/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1186/s40246-021-00314-7.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        2,
        26
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        2,
        26
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1159/000495173",
      "author": "F He",
      "doi-asserted-by": "publisher",
      "first-page": "186",
      "issue": "1",
      "journal-title": "Cell Physiol Biochem",
      "key": "314_CR1",
      "unstructured": "He F, et al. Inhibition of microRNA-124 reduces cardiomyocyte apoptosis following myocardial infarction via targeting STAT3. Cell Physiol Biochem. 2018;51(1):186–200.",
      "volume": "51",
      "year": "2018"
    },
    {
      "DOI": "10.1056/NEJMra1606915",
      "author": "JL Anderson",
      "doi-asserted-by": "publisher",
      "first-page": "2053",
      "issue": "21",
      "journal-title": "N Engl J Med",
      "key": "314_CR2",
      "unstructured": "Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med. 2017;376(21):2053–64.",
      "volume": "376",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrcardio.2014.28",
      "author": "NG Frangogiannis",
      "doi-asserted-by": "publisher",
      "first-page": "255",
      "issue": "5",
      "journal-title": "Nat Rev Cardiol",
      "key": "314_CR3",
      "unstructured": "Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255–65.",
      "volume": "11",
      "year": "2014"
    },
    {
      "DOI": "10.1056/NEJMe1914378",
      "doi-asserted-by": "crossref",
      "key": "314_CR4",
      "unstructured": "Newby LK. Inflammation as a treatment target after acute myocardial infarction. N Engl J Med. 2019;381(26):2562–63."
    },
    {
      "DOI": "10.1161/ATVBAHA.118.312037",
      "author": "H Noels",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "issue": "4",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "314_CR5",
      "unstructured": "Noels H, Weber C, Koenen RR. Chemokines as therapeutic targets in cardiovascular disease. Arterioscler Thromb Vasc Biol. 2019;39(4):583–92.",
      "volume": "39",
      "year": "2019"
    },
    {
      "key": "314_CR6",
      "unstructured": "Jones DP, True HD. Leukocyte trafficking in cardiovascular disease: insights from experimental models. Mediators Inflamm. 2017;2017:9746169."
    },
    {
      "DOI": "10.1089/scd.2019.0154",
      "doi-asserted-by": "crossref",
      "key": "314_CR7",
      "unstructured": "Song YL, et al. Mesenchymal stem cell-platelet aggregates increased in the peripheral blood of patients with acute myocardial infarction and might depend on the CXCR4/SDF-1 axis. Stem Cells Dev. 2019;28(24):1607–19."
    },
    {
      "DOI": "10.3390/jcm8050659",
      "doi-asserted-by": "crossref",
      "key": "314_CR8",
      "unstructured": "Lin CF, et al. Potential effects of CXCL9 and CCL20 on cardiac fibrosis in patients with myocardial infarction and isoproterenol-treated rats. J Clin Med. 2019;8(5):659."
    },
    {
      "DOI": "10.1016/j.cmet.2018.05.002",
      "author": "C Winter",
      "doi-asserted-by": "publisher",
      "first-page": "175",
      "issue": "1",
      "journal-title": "Cell Metab",
      "key": "314_CR9",
      "unstructured": "Winter C, et al. Chrono-pharmacological targeting of the CCL2-CCR2 axis ameliorates atherosclerosis. Cell Metab. 2018;28(1):175–82 e5.",
      "volume": "28",
      "year": "2018"
    },
    {
      "DOI": "10.1160/TH07-01-0035",
      "author": "A Ludwig",
      "doi-asserted-by": "publisher",
      "first-page": "694",
      "issue": "5",
      "journal-title": "Thromb Haemost",
      "key": "314_CR10",
      "unstructured": "Ludwig A, Weber C. Transmembrane chemokines: versatile ‘special agents’ in vascular inflammation. Thromb Haemost. 2007;97(5):694–703.",
      "volume": "97",
      "year": "2007"
    },
    {
      "DOI": "10.1161/HYPERTENSIONAHA.113.01954",
      "author": "AE Norlander",
      "doi-asserted-by": "publisher",
      "first-page": "1008",
      "issue": "6",
      "journal-title": "Hypertension",
      "key": "314_CR11",
      "unstructured": "Norlander AE, Saleh MA, Madhur MS. CXCL16: a chemokine-causing chronic kidney disease. Hypertension. 2013;62(6):1008–10.",
      "volume": "62",
      "year": "2013"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.105.540583",
      "author": "AM Aslanian",
      "doi-asserted-by": "publisher",
      "first-page": "583",
      "issue": "6",
      "journal-title": "Circulation",
      "key": "314_CR12",
      "unstructured": "Aslanian AM, Charo IF. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis. Circulation. 2006;114(6):583–90.",
      "volume": "114",
      "year": "2006"
    },
    {
      "DOI": "10.1161/ATVBAHA.119.312633",
      "author": "T Andersen",
      "doi-asserted-by": "publisher",
      "first-page": "2402",
      "issue": "11",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "314_CR13",
      "unstructured": "Andersen T, et al. C-X-C ligand 16 is an independent predictor of cardiovascular death and morbidity in acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2019;39(11):2402–10.",
      "volume": "39",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cjca.2014.12.026",
      "author": "KG Shyu",
      "doi-asserted-by": "publisher",
      "first-page": "679",
      "issue": "5",
      "journal-title": "Can J Cardiol",
      "key": "314_CR14",
      "unstructured": "Shyu KG, et al. MicroRNA-208a increases myocardial endoglin expression and myocardial fibrosis in acute myocardial infarction. Can J Cardiol. 2015;31(5):679–90.",
      "volume": "31",
      "year": "2015"
    },
    {
      "DOI": "10.1038/s41598-017-07578-x",
      "author": "C Sun",
      "doi-asserted-by": "publisher",
      "first-page": "7460",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "314_CR15",
      "unstructured": "Sun C, et al. MicroRNA-98 negatively regulates myocardial infarction-induced apoptosis by down-regulating Fas and caspase-3. Sci Rep. 2017;7(1):7460.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.ijcard.2019.09.055",
      "author": "A Li",
      "doi-asserted-by": "publisher",
      "first-page": "137",
      "journal-title": "Int J Cardiol",
      "key": "314_CR16",
      "unstructured": "Li A, et al. MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway. Int J Cardiol. 2020;307:137–45.",
      "volume": "307",
      "year": "2020"
    },
    {
      "DOI": "10.1002/jcp.28222",
      "doi-asserted-by": "publisher",
      "key": "314_CR17",
      "unstructured": "Sun Y, Feng L, Li J. miR-545 promoted enterovirus 71 replication via directly targeting phosphatase and tensin homolog and tumor necrosis factor receptor-associated factor 6. 2019. Online ahead of print. https://doi.org/10.1002/jcp.28222."
    },
    {
      "DOI": "10.1038/s41419-019-1863-z",
      "author": "X Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "616",
      "issue": "8",
      "journal-title": "Cell Death Dis",
      "key": "314_CR18",
      "unstructured": "Zhang X, et al. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis. 2019;10(8):616.",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.18632/oncotarget.8129",
      "author": "Z Liu",
      "doi-asserted-by": "publisher",
      "first-page": "25350",
      "issue": "18",
      "journal-title": "Oncotarget",
      "key": "314_CR19",
      "unstructured": "Liu Z, et al. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma. Oncotarget. 2016;7(18):25350–65.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.biopha.2018.09.009",
      "author": "L Changjun",
      "doi-asserted-by": "publisher",
      "first-page": "347",
      "journal-title": "Biomed Pharmacother",
      "key": "314_CR20",
      "unstructured": "Changjun L, et al. MiR-545-3p/MT1M axis regulates cell proliferation, invasion and migration in hepatocellular carcinoma. Biomed Pharmacother. 2018;108:347–54.",
      "volume": "108",
      "year": "2018"
    },
    {
      "DOI": "10.1002/clc.20041",
      "author": "CR Conti",
      "doi-asserted-by": "publisher",
      "first-page": "I1",
      "issue": "2 Suppl 1",
      "journal-title": "Clin Cardiol",
      "key": "314_CR21",
      "unstructured": "Conti CR. Re-thinking angina. Clin Cardiol. 2007;30(2 Suppl 1):I1–3.",
      "volume": "30",
      "year": "2007"
    },
    {
      "author": "J Martins e Silva",
      "first-page": "537",
      "issue": "5",
      "journal-title": "Rev Port Cardiol",
      "key": "314_CR22",
      "unstructured": "Martins e Silva J. Ischemic myocardial disease as an example of a thrombotic event. A historical note. Rev Port Cardiol. 2006;25(5):537–43.",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s00109-015-1317-8",
      "author": "EP van der Vorst",
      "doi-asserted-by": "publisher",
      "first-page": "963",
      "issue": "9",
      "journal-title": "J Mol Med (Berl)",
      "key": "314_CR23",
      "unstructured": "van der Vorst EP, Doring Y, Weber C. Chemokines and their receptors in atherosclerosis. J Mol Med (Berl). 2015;93(9):963–71.",
      "volume": "93",
      "year": "2015"
    },
    {
      "DOI": "10.1161/ATVBAHA.113.301655",
      "author": "A Zernecke",
      "doi-asserted-by": "publisher",
      "first-page": "742",
      "issue": "4",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "314_CR24",
      "unstructured": "Zernecke A, Weber C. Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol. 2014;34(4):742–50.",
      "volume": "34",
      "year": "2014"
    },
    {
      "DOI": "10.1161/CIRCULATIONAHA.109.916346",
      "author": "M Nahrendorf",
      "doi-asserted-by": "publisher",
      "first-page": "2437",
      "issue": "22",
      "journal-title": "Circulation",
      "key": "314_CR25",
      "unstructured": "Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010;121(22):2437–45.",
      "volume": "121",
      "year": "2010"
    },
    {
      "DOI": "10.1161/hq1001.096652",
      "author": "M Minami",
      "doi-asserted-by": "publisher",
      "first-page": "1796",
      "issue": "11",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "314_CR26",
      "unstructured": "Minami M, et al. Expression of SR-PSOX, a novel cell-surface scavenger receptor for phosphatidylserine and oxidized LDL in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2001;21(11):1796–800.",
      "volume": "21",
      "year": "2001"
    },
    {
      "DOI": "10.1161/CIRCHEARTFAILURE.108.821074",
      "author": "CP Dahl",
      "doi-asserted-by": "publisher",
      "first-page": "624",
      "issue": "6",
      "journal-title": "Circ Heart Fail",
      "key": "314_CR27",
      "unstructured": "Dahl CP, et al. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling. Circ Heart Fail. 2009;2(6):624–32.",
      "volume": "2",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.atherosclerosis.2015.11.022",
      "author": "LE Laugsand",
      "doi-asserted-by": "publisher",
      "first-page": "188",
      "journal-title": "Atherosclerosis",
      "key": "314_CR28",
      "unstructured": "Laugsand LE, et al. Soluble CXCL16 and risk of myocardial infarction: the HUNT study in Norway. Atherosclerosis. 2016;244:188–94.",
      "volume": "244",
      "year": "2016"
    },
    {
      "DOI": "10.1155/2017/9463272",
      "doi-asserted-by": "crossref",
      "key": "314_CR29",
      "unstructured": "Xu S, et al. The impact of tagSNPs in CXCL16 gene on the risk of myocardial infarction in a Chinese Han population. Dis Markers. 2017;2017:9463272."
    },
    {
      "DOI": "10.1002/cam4.1520",
      "doi-asserted-by": "crossref",
      "key": "314_CR30",
      "unstructured": "Ma M, et al. MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer. Cancer Med. 2018;7(6):2452–62. "
    },
    {
      "DOI": "10.1002/jcp.27601",
      "doi-asserted-by": "crossref",
      "key": "314_CR31",
      "unstructured": "Hu C, et al. Overexpressed circ_0067934 acts as an oncogene to facilitate cervical cancer progression via the miR-545/EIF3C axis. J Cell Physiol. 2019;234(6):9225–32."
    },
    {
      "author": "Z Qiu",
      "first-page": "3025",
      "issue": "4",
      "journal-title": "Exp Ther Med",
      "key": "314_CR32",
      "unstructured": "Qiu Z, et al. miR-370 inhibits the oxidative stress and apoptosis of cardiac myocytes induced by hydrogen peroxide by targeting FOXO1. Exp Ther Med. 2019;18(4):3025–31.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.3389/fphar.2019.00463",
      "author": "R Bruen",
      "doi-asserted-by": "publisher",
      "first-page": "463",
      "journal-title": "Front Pharmacol",
      "key": "314_CR33",
      "unstructured": "Bruen R, Fitzsimons S, Belton O. miR-155 in the resolution of atherosclerosis. Front Pharmacol. 2019;10:463.",
      "volume": "10",
      "year": "2019"
    },
    {
      "author": "PP Wang",
      "first-page": "6119",
      "issue": "18",
      "journal-title": "Eur Rev Med Pharmacol Sci",
      "key": "314_CR34",
      "unstructured": "Wang PP, et al. MiR-223 promotes cardiomyocyte apoptosis by inhibiting Foxo3a expression. Eur Rev Med Pharmacol Sci. 2018;22(18):6119–26.",
      "volume": "22",
      "year": "2018"
    },
    {
      "DOI": "10.1111/jpi.12369",
      "doi-asserted-by": "publisher",
      "key": "314_CR35",
      "unstructured": "Sánchez DI, et al. Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma. J Pineal Res. 2017;62(1). https://doi.org/10.1111/jpi.12369."
    },
    {
      "DOI": "10.3389/fimmu.2018.02750",
      "author": "F Lepore",
      "doi-asserted-by": "publisher",
      "first-page": "2750",
      "journal-title": "Front Immunol",
      "key": "314_CR36",
      "unstructured": "Lepore F, et al. CXCL16/CXCR6 axis drives microglia/macrophages phenotype in physiological conditions and plays a crucial role in glioma. Front Immunol. 2018;9:2750.",
      "volume": "9",
      "year": "2018"
    },
    {
      "DOI": "10.18632/oncotarget.3194",
      "author": "H Mir",
      "doi-asserted-by": "publisher",
      "first-page": "9985",
      "issue": "12",
      "journal-title": "Oncotarget",
      "key": "314_CR37",
      "unstructured": "Mir H, et al. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases. Oncotarget. 2015;6(12):9985–98.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1161/ATVBAHA.107.161174",
      "author": "A Zernecke",
      "doi-asserted-by": "publisher",
      "first-page": "1897",
      "issue": "11",
      "journal-title": "Arterioscler Thromb Vasc Biol",
      "key": "314_CR38",
      "unstructured": "Zernecke A, Shagdarsuren E, Weber C. Chemokines in atherosclerosis: an update. Arterioscler Thromb Vasc Biol. 2008;28(11):1897–908.",
      "volume": "28",
      "year": "2008"
    },
    {
      "DOI": "10.1161/CIRCRESAHA.112.276444",
      "author": "O Borst",
      "doi-asserted-by": "publisher",
      "first-page": "1297",
      "issue": "10",
      "journal-title": "Circ Res",
      "key": "314_CR39",
      "unstructured": "Borst O, et al. The inflammatory chemokine CXC motif ligand 16 triggers platelet activation and adhesion via CXC motif receptor 6-dependent phosphatidylinositide 3-kinase/Akt signaling. Circ Res. 2012;111(10):1297–307.",
      "volume": "111",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.cardiores.2003.12.004",
      "author": "W Bao",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "issue": "3",
      "journal-title": "Cardiovasc Res",
      "key": "314_CR40",
      "unstructured": "Bao W, et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res. 2004;61(3):548–58.",
      "volume": "61",
      "year": "2004"
    },
    {
      "DOI": "10.1371/journal.pone.0033491",
      "author": "D Sun",
      "doi-asserted-by": "publisher",
      "issue": "3",
      "journal-title": "PLoS One",
      "key": "314_CR41",
      "unstructured": "Sun D, et al. Luteolin limits infarct size and improves cardiac function after myocardium ischemia/reperfusion injury in diabetic rats. PLoS One. 2012;7(3):e33491.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1007/s11906-012-0309-0",
      "author": "J Ahn",
      "doi-asserted-by": "publisher",
      "first-page": "510",
      "issue": "6",
      "journal-title": "Curr Hypertens Rep",
      "key": "314_CR42",
      "unstructured": "Ahn J, Kim J. Mechanisms and consequences of inflammatory signaling in the myocardium. Curr Hypertens Rep. 2012;14(6):510–6.",
      "volume": "14",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0008-6363(03)00339-0",
      "author": "PR Woldbaek",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "issue": "1",
      "journal-title": "Cardiovasc Res",
      "key": "314_CR43",
      "unstructured": "Woldbaek PR, et al. Increased cardiac IL-18 mRNA, pro-IL-18 and plasma IL-18 after myocardial infarction in the mouse; a potential role in cardiac dysfunction. Cardiovasc Res. 2003;59(1):122–31.",
      "volume": "59",
      "year": "2003"
    },
    {
      "author": "L Yao",
      "first-page": "1048",
      "issue": "3",
      "journal-title": "Int J Mol Med",
      "key": "314_CR44",
      "unstructured": "Yao L, et al. Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int J Mol Med. 2019;44(3):1048–62.",
      "volume": "44",
      "year": "2019"
    }
  ],
  "reference-count": 44,
  "references-count": 44,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00314-7"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "C-X-C motif chemokine 16, modulated by microRNA-545, aggravates myocardial damage and affects the inflammatory responses in myocardial infarction"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}